Week in review: Brain power, shady business, integrin inhibition
- Posted on: Jun 7 2019
- Leave a response
This week, children retain visual perception after surgery to remove the visual cortex, a Florida clinic is forced to halt unapproved stem cell treatments and risuteganib shines in a phase 2 trial for dry AMD.
Source: AAO
Posted in: Uncategorized
